期刊
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
卷 32, 期 -, 页码 S197-S199出版社
ELSEVIER
DOI: 10.1016/S0924-8579(09)70002-0
关键词
Antibiotic resistance; Empirical therapy; Treatment options
Multidrug microbial resistance poses major challenges to the management of infection, particularly with the paucity of new drugs with activity against these bacteria. Since the turn of this century a few new antibiotics have been licensed, including linezolid, daptomycin and tigecycline. This supplement reports data presented at the 13th International Congress of Infectious Diseases held in Kuala Lumpur in June 2008. Dr R. Isturiz reviews the data on global resistance trends and the potential impact on empirical therapy; Dr J.-H. Song reviews new agents on the antimicrobial horizon; and the. final paper in the supplement, by Dr L. R. Peterson, reviews the role of tigecycline in the management of complicated intra-abdominal and skin and soft tissue infections. (C) 2008 Elsevier B. V. and the International Society of Chemotherapy. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据